A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
Clinical trial NCT00088634 · COMPLETED
Trial details
- NCT number
- NCT00088634
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Primary completion
- 2004-12-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.